CB2 Insights Announces Industry’s First Full-Scale Hemp-based Cannabidiol (CBD) Prospective Trial in Partnership with GL Brands (Formerly Freedom Leaf Inc.)

NEXT STORY
Salarius Pharmaceuticals Receives FDA Fast Track Designation for Lead Drug Candidate, Seclidemstat, in Relapsed or Refractory Ewing Sarcoma
PREV STORY
BeiGene Announces Results of Phase 3 ASPEN Trial of Zanubrutinib Compared to Ibrutinib for the Treatment of Patients with Waldenström’s Macroglobulinemia
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Kura Oncology to Host Investor Day on November 16, 2017

SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., (Nasdaq:KURA) a clinical-stage ...

author_avatar
NASDAQ Market News

IMV Leadership to Present Respiratory Syncytial Virus (RSV) Research at RespiDART 2018

DARTMOUTH, Nova Scotia, Nov. 26, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: ...

author_avatar
NASDAQ Market News

Sip Tips: 5 Ways to Use Water for Weight Loss

NEW YORK, Jan. 25, 2016 (GLOBE NEWSWIRE) -- You've probably already heard that drinking ...

author_avatar
NASDAQ Market News